Physicians Still Hopeful About Desmoteplase for the Treatment of Acute Ischemic Stroke Despite Negative Results
Surveyed Neurologists Identify a Six-Hour Treatment Window as Area of
Greatest Dissatisfaction, According to a New Report from Decision Resources
WALTHAM, Mass., Jan. 30 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms for pharmaceutical and
Bat Saliva-Based Stroke Drug Disappoints in Trial
... earlier and smaller studies showed a benefit when desmoteplase
was given intravenously to reopen brain arteries b...trial, called DIAS-2, between stroke victims given desmoteplase
and those who got a placebo, said a report to be p..., which is in the planning stage, Furlan added.
was originally spotted in the saliva of the vampir...